PASG

NASD Passage Bio, Inc.
Oct 8, 2026 · 6:51 PM ET LAST TRADE Market Closed

$3.73 ↓ -0.05 (-1.32%) Trading Down from the previous close of $3.78, $0.10 below the day’s high of $3.83

YTD change
-68.39%
vs 20-day SMA
-19.61%
vs 200-day SMA
-47.60%

Price ranges

Previous day
$3.76 $4.05
open $4.00 close $3.86
-$0.15 (-3.63%)
Today
$3.62 $3.83
open $3.77 now $3.73
-$0.04 (-1.06%)
Past week
$3.76 $4.73
from $4.50 now $3.73
-$0.77 (-17.11%)
Past month
$3.76 $5.22
from $4.94 now $3.73
-$1.21 (-24.49%)
This year
$3.29 $20.00
from $11.80 now $3.73
-$8.07 (-68.39%)

Price & Performance

-5.43 (-58.50%) / 6M

$3.21$6.32$9.43$12.53Apr 8Jul 9Oct 7

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 99.5% away from all-time highs of $764.60
  • PASG is down 68% since the beginning of the year
  • PASG is down 55% over the past 12 months
  • PASG is down 24% over the past 1 month
  • 3% of all PASG investors are betting against PASG

PASG reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -53.4%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-2.44
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $-11785300.0
Beta 2.64

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$24.2M
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $12.0M

Passage Bio, Inc. operates as a genetic medicines company. It focuses on development of therapies for central nervous system disorders. The company was founded by Stephen P. Squinto, Tadataka Yamada, David A. Socks, Aditya Kohli, and James M. Wilson in July 2017 and is headquartered in Philadelphia, PA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $413.08 +2.60%
MRNA Moderna, Inc. $196.48 +4.81%
RVMD Revolution Medicines, Inc. $200.87 +0.50%
ROIV Roivant Sciences Ltd. $34.75 -2.20%
BNTX BioNTech SE Sponsored ADR $95.25 -0.50%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.